Needle Type Doesn't Change Epidural Vascular Uptake Risk

This article originally appeared here.
Share this content:
Needle Type Doesn't Change Epidural Vascular Uptake Risk
Needle Type Doesn't Change Epidural Vascular Uptake Risk

MONDAY, Oct. 19, 2015 (HealthDay News) -- Blunt-tip and pencil-point needles have comparable risks of inadvertent vascular injection during lumbosacral transforaminal injections, according to a study published online Oct. 7 in Pain Medicine.

Matthew Smuck, M.D., from Stanford University in Redwood City, California, and colleagues determined the presence or absence of vascular uptake after fluoroscopically guided lumbosacral transforaminal epidural injections. Using three different needle types, the same interventional spine physician performed the procedures on 475 consecutive, consenting patients. Contrast injection under live fluoroscopy was used to determine vascular uptake.

The researchers found that 58 of the 475 injections had vascular uptake. The incidence of inadvertent vascular uptake was 16.6 percent in the pencil-point group and 15.6 percent in the blunt-tip group compared with 4.9 percent in the catheter-extension group. The incidence of functional pitfalls was significantly lower in the pencil-point group than in either the catheter-extension or blunt-tip needle group.

"Blunt-tip and pencil-point needles have comparable risk of inadvertent vascular injection during lumbosacral transforaminal injections. Catheter-extension needles demonstrated a reduced incidence of vascular uptake but also result in a significantly higher rate of functional pitfalls that limits their usefulness in routine practice," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »